Skip to content

Clinical trials

Completed Central Nervous System Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Completed Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20121
20132
20151
20162
20171
20191
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
IRCCS San Raffaele Roma2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Danilo Toni1
Eli Lilly and Company1
Guerbet1
I.R.C.C.S. Fondazione Santa Lucia1
Novartis Pharmaceuticals1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases14
Brain Diseases12
Nervous System Diseases7
Movement Disorders6
Neurodegenerative Diseases6
Parkinson Disease4
Parkinsonian Disorders4
Cerebrovascular Disorders3
Mental Disorders3
Neurologic Manifestations3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.